Nicholas lain James Paton

Paton Nicholas lain James

Appointment(s)
  • Professor, Department of Medicine
  • Senior Consultant, Division of Infectious Disease, University Medicine Cluster, National University Health System
Administrative Appointment(s)
  • Research Director, University Medicine Cluster, National University Health System
  • Director, SPRINT-TB Programme, National University Health System
  • Lead, Tuberculosis Summit Research Programme, National University Health System
Academic Qualifications
  • BA, University of Cambridge, United Kingdom
  • MBBChir, University of Cambridge, United Kingdom
  • MA, University of Cambridge, United Kingdom
  • MD, University of Cambridge, United Kingdom
  • MSc (Epidemiology), University of Cambridge, United Kingdom
Research Interest(s)
  • HIV
  • Tuberculosis
  • Clinical Trials
  • Treatment
Recent Publications
  • 1. Hakim JG, Thompson J, Kityo C, Hoppe A, Kambugu A, van Oosterhout JJ, Lugemwa A, Siika A, Mwebaze R, Mweemba A et al. 2018 Jan. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Lancet Infect Dis. 18(1):47-57. doi: 10.1016/S1473-3099(17)30630-8.
  • 2. Thomas BA, Molton JS, Leek F, Pang Y, Totman JJ, Paton NI, Townsend DW. 2017 Nov. A comparison of F-18-FDG PET/MR with PET/CT in pulmonary tuberculosis. Nuclear Medicine Communications. 38(11):971-978. doi: 10.1097/MNM.0000000000000743.
  • 3. Hoppe A, Giuliano M, Lugemwa A, Thompson JA, Floridia M, Walker AS, Senoga I, Abwola MC, Pirillo MF, Kityo CM et al. 2017 Oct. HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa. doi: 10.3851/IMP3200.
  • 4. Parmar MKB, Sydes MR, Cafferty FH, Choodari-Oskooei B, Langley RE, Brown L, Phillips PPJ, Spears MR, Rowley S, Kaplan R et al. 2017 Oct. Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols. Clinical Trials. 14(5):451-461. doi: 10.1177/1740774517725697.
  • 5. Kanters S, Socias ME, Paton NI, Vitoria M, Doherty M, Ayers D, Popoff E, Chan K, Cooper DA, Wiens MO et al. 2017 Oct. Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis. The Lancet HIV. 4(10):e433-e441. doi: 10.1016/S2352-3018(17)30109-1.